CBU
SLS icon

CIBC Bancorp USA’s SELLAS Life Sciences SLS Stock Holding History

CIBC Bancorp USA’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Buy
+10,442
New +$72.1K ﹤0.01% 1811
2025
Q3 		$17.3K Buy
+10,736
New +$19.1K ﹤0.01% 1459

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CIBC Bancorp USA's SLS Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 10,442 shares worth $154K. The stake represents ﹤0.01% of the portfolio and ranks #1811 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in SLS as recently as Q3 2025.

CIBC Bancorp USA first reported a position in SLS in Q3 2025 and has held it in 2 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • CIBC Bancorp USA held 10,442 shares of SELLAS Life Sciences worth $154K as of Q2 2026.
  • SELLAS Life Sciences was a new CIBC Bancorp USA position in Q2 2026.
  • SELLAS Life Sciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1811 holding.
  • CIBC Bancorp USA first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 2 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.